Phase II Study of AZD 2171 in Patients With Recurrent Small Cell Lung Cancer.
Phase of Trial: Phase II
Latest Information Update: 22 Oct 2016
At a glance
- Drugs Cediranib (Primary)
- Indications Small cell lung cancer
- Focus Therapeutic Use
- 16 Mar 2010 Planned end date (1 Mar 2010) added as reported by ClinicalTrials.gov.
- 16 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 May 2008 Status changed from suspended to in progress.